With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through our nearly 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Phase I Study of Lentivirus Engineered Autologous AML Cells Expressing IL-12 in Children and Young Adults with Relapsed AML||Children's Hospital of Wisconsin - Milwaukee / Michael Burke, MD & Jeffrey Medin, MD/PhD||Reach Grants||2017||Wisconsin|
|Natural Killer T cells with an IL-15-armored GD2-specific CAR for Children with Neuroblastoma||Baylor College of Medicine / Andras Heczey, MD||Bio-Therapeutic Impact Award||2017||Texas|
|Characterization of Novel OTX2-semaphorin Gene Signaling Pathways Regulating the ‘Grow and Go’ Arms of Highly Aggressive Medulloblastomas||University of Manitoba / Tamra Werbowetski-Ogilvie, PhD||Innovation Grants||2017||Manitoba|
|Alternative Splicing in the Pathogenesis of Acute Lymphoblastic Leukemia||Children's Hospital of Philadelphia / Andrei Thomas-Tikhonenko, PhD||Innovation Grants||2017||Pennsylvania|
|De-escalation of Radiotherapy for Medulloblastoma by a Novel DNA Damage Checkpoint Inhibitor||Feinstein Institute for Medical Research - North Shore / Marc Symons, PhD||Innovation Grants||2017||New York|
|3-D Printed Self-fitting Shape Memory Bone Grafts for Smart Pediatric Skeletal Reconstruction||University of Massachusetts Medical School / Jie Song, PhD||Innovation Grants||2017||Massachusetts|
|Targeted Degradation of Proliferative Transcription Factors in Pediatric Cancers||University of California at Santa Cruz / Seth Rubin, PhD||Innovation Grants||2017||California|
|Mechanisms of OTX2 Mediated Chromatin Regulation in Medulloblastoma||Massachusetts General Hospital / Miguel Rivera, MD||Innovation Grants||2017||Massachusetts|
|Novel Approaches for Epigenetic Therapy for Relapsed Acute Lymphoblastic Leukemia||The Johns Hopkins University School of Medicine / Linda Resar, MD & Andrei Thomas-Tikhonenko, PhD||Innovation Grants||2017||Maryland|
|Establishing the Function of Novel MicroRNAs Associated with Resistance and Relapse in Pediatric AML||Fred Hutchinson Cancer Research Center / Vivian Oehler, MD & Soheil Meshinchi, MD/PhD||Innovation Grants||2017||Washington|